Rhumbline Advisers Has $1.26 Million Position in Liquidia Technologies, Inc. $LQDA

Rhumbline Advisers raised its stake in shares of Liquidia Technologies, Inc. (NASDAQ:LQDAFree Report) by 6.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 85,463 shares of the company’s stock after purchasing an additional 4,811 shares during the period. Rhumbline Advisers owned 0.10% of Liquidia Technologies worth $1,261,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Cetera Investment Advisers grew its stake in Liquidia Technologies by 4.3% in the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company’s stock valued at $367,000 after buying an additional 1,277 shares during the last quarter. Bluefin Capital Management LLC bought a new stake in Liquidia Technologies during the first quarter valued at about $250,000. Deutsche Bank AG grew its position in shares of Liquidia Technologies by 53.4% in the fourth quarter. Deutsche Bank AG now owns 51,075 shares of the company’s stock valued at $601,000 after purchasing an additional 17,790 shares during the last quarter. Boothbay Fund Management LLC increased its stake in shares of Liquidia Technologies by 18.7% in the first quarter. Boothbay Fund Management LLC now owns 662,873 shares of the company’s stock worth $9,777,000 after purchasing an additional 104,215 shares during the period. Finally, Millennium Management LLC acquired a new position in shares of Liquidia Technologies during the 4th quarter worth about $526,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Liquidia Technologies Stock Down 3.6%

Shares of NASDAQ:LQDA opened at $23.78 on Friday. Liquidia Technologies, Inc. has a 12 month low of $9.71 and a 12 month high of $29.94. The company’s 50-day moving average price is $23.11 and its two-hundred day moving average price is $17.51. The company has a quick ratio of 2.41, a current ratio of 2.49 and a debt-to-equity ratio of 9.84. The firm has a market cap of $2.05 billion, a P/E ratio of -13.99 and a beta of 0.22.

Liquidia Technologies (NASDAQ:LQDAGet Free Report) last announced its earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative return on equity of 232.96% and a negative net margin of 732.17%.The company had revenue of $8.84 million during the quarter, compared to the consensus estimate of $3.90 million. The firm’s revenue was up 141.5% compared to the same quarter last year. As a group, research analysts forecast that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Needham & Company LLC raised their target price on Liquidia Technologies from $32.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, August 12th. Jefferies Financial Group started coverage on Liquidia Technologies in a research report on Friday, August 15th. They issued a “buy” rating and a $43.00 price objective for the company. Raymond James Financial boosted their target price on shares of Liquidia Technologies from $33.00 to $41.00 and gave the stock a “strong-buy” rating in a research report on Wednesday, August 13th. BTIG Research reiterated a “buy” rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. Finally, Bank of America decreased their price target on shares of Liquidia Technologies from $25.00 to $23.00 and set a “buy” rating on the stock in a research report on Wednesday, June 11th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Liquidia Technologies presently has an average rating of “Buy” and an average target price of $32.11.

View Our Latest Stock Analysis on Liquidia Technologies

Insider Transactions at Liquidia Technologies

In other Liquidia Technologies news, CEO Roger Jeffs sold 20,252 shares of the company’s stock in a transaction on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $289,198.56. Following the transaction, the chief executive officer owned 1,038,560 shares of the company’s stock, valued at approximately $14,830,636.80. This represents a 1.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jason Adair sold 26,057 shares of the stock in a transaction on Thursday, August 28th. The shares were sold at an average price of $27.86, for a total value of $725,948.02. Following the completion of the transaction, the insider owned 171,029 shares in the company, valued at $4,764,867.94. The trade was a 13.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 881,097 shares of company stock worth $23,689,864 over the last ninety days. 26.50% of the stock is currently owned by insiders.

About Liquidia Technologies

(Free Report)

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Further Reading

Institutional Ownership by Quarter for Liquidia Technologies (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.